Form 4: Replimune Group Officer Andrew Schwendenman Reports Stock Option Grant and RSU Vesting

Andrew Schwendenman, Chief Accounting Officer of Replimune Group, reports the acquisition of stock options and vesting of restricted stock units (RSUs) in a recent SEC filing.

Summary

• Andrew Schwendenman, Chief Accounting Officer of Replimune Group, filed a Form 4 with the SEC.
• The filing reports the acquisition of 53,325 employee stock options at an exercise price of $7.73 on April 1, 2024.
• These options vest over time, with 25% vesting on April 1, 2025, and the remainder vesting in 36 approximately equal monthly installments thereafter.
• The filing also indicates the vesting of 17,775 restricted stock units (RSUs) on April 1, 2024, resulting in Mr. Schwendenman beneficially owning 40,536 shares of common stock.
• These RSUs vest over time, with 25% vesting on May 15, 2025, and the remainder vesting in three approximately equal annual installments thereafter until May 15, 2028, subject to continuous service.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating standard compensation practices. There's no explicit positive or negative news, just information about stock options and RSU vesting.

Positives

• The granting of stock options and vesting of RSUs can be seen as a positive sign, aligning the officer's interests with those of the shareholders.
• The vesting schedules incentivize continued service to the company.

Future Outlook

The vesting schedules for both the stock options and RSUs suggest an expectation of continued service and contribution from the Chief Accounting Officer.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for insights into management's confidence in the company's prospects.

Comparison to Industry Standards

• Stock option grants and RSU vesting are common compensation practices in the biotechnology industry, used to attract and retain talent.
• The vesting schedules described are fairly standard, aligning with typical industry practices for incentivizing long-term commitment.

Stakeholder Impact

• The transactions reported in the Form 4 have a minor impact on shareholders, as they reflect changes in insider ownership.
• The vesting schedules incentivize the officer's continued service, potentially benefiting the company and its stakeholders.

Key Dates